Showing results (21-30 of 69) with videos related to
Sort By:
Pageof 7
Organic Letters|July 4, 2013
Total synthesis and biological activity of natural product Urukthapelstatin AChun-Chieh Lin, Worawan Tantisantisom, Shelli R McAlpineJournal of Medicinal Chemistry|April 7, 2007
Scaffold targeting drug-resistant colon cancersKaterina Otrubova, Kathleen L McGuire, Shelli R McAlpineChemmedchem|February 1, 2017
How Selective are Hsp90 Inhibitors for Cancer Cells over Normal Cells?Yao Wang, Yen Chin Koay, Shelli R McAlpineBioorganic & Medicinal Chemistry Letters|July 13, 2015
Regulating the master regulator: Controlling heat shock factor 1 as a chemotherapy approachJeanette R McConnell, Laura K Buckton, Shelli R McAlpineChemistry (Weinheim an Der Bergstrasse, Germany)|September 3, 2020
Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic DevelopmentLaura K Buckton, Marwa N Rahimi, Shelli R McAlpineBioorganic & Medicinal Chemistry Letters|December 24, 2013
A heat shock protein 90 inhibitor that modulates the immunophilins and regulates hormone receptors without inducing the heat shock responseJeanette R McConnell, Leslie A Alexander, Shelli R McAlpineRSC Medicinal Chemistry|April 26, 2021
Using NMR to identify binding regions for N and C-terminal Hsp90 inhibitors using Hsp90 domainsJeanette R McConnell, H Jane Dyson, Shelli R McAlpineBioorganic & Medicinal Chemistry Letters|August 11, 2007
Identification of Sansalvamide a analog potent against pancreatic cancer cell linesPo-Shen Pan, Kathleen L McGuire, Shelli R McAlpineBioorganic & Medicinal Chemistry Letters|December 16, 2014
The fungal natural product (1S,3S)-austrocortirubin induces DNA damage in HCT116 cells via a mechanism unique from other DNA damaging agentsYao Wang, Md Amirul Islam, Rohan A Davis, et al.ACS Chemical Biology|September 29, 2011
Macrocycles that inhibit the binding between heat shock protein 90 and TPR-containing proteinsVeronica C Ardi, Leslie D Alexander, Victoria A Johnson, et al.Pageof 7